Display options
Cite
Bertelsmann A. Statutory regulations governing the reporting of adverse reactions. Int J Risk Saf Med. 1996;9(2):101-6doi: 10.3233/JRS-1996-9207.
Bertelsmann, A. (1996). Statutory regulations governing the reporting of adverse reactions. The International journal of risk & safety in medicine, 9(2), 101-6. https://doi.org/10.3233/JRS-1996-9207
Bertelsmann, A. "Statutory regulations governing the reporting of adverse reactions." The International journal of risk & safety in medicine vol. 9,2 (1996): 101-6. doi: https://doi.org/10.3233/JRS-1996-9207
Bertelsmann A. Statutory regulations governing the reporting of adverse reactions. Int J Risk Saf Med. 1996;9(2):101-6. doi: 10.3233/JRS-1996-9207. PMID: 23510848.
Copy Download .nbib Format: NLM
Share it on

Int J Risk Saf Med. 1996;9(2):101-6. doi: 10.3233/JRS-1996-9207.

Statutory regulations governing the reporting of adverse reactions.

The International journal of risk & safety in medicine

A Bertelsmann

Affiliations

  1. Bundesinstitut für Arzneimittel und Medizinprodukte, Seestraße 10, D-13353 Berlin, Germany.

PMID: 23510848 DOI: 10.3233/JRS-1996-9207

Abstract

Under the Drug Law (AMG) of 1976, applicants for marketing authorisations were obliged to notify the competent authorities of any new information about the product.When the Second Amendment came into force on 17 February 1987, the regulation became tighter in so far as applicants were obliged to notify the competent authority once they get to know of any suspected adverse reaction or interaction with other agents that could be a health hazard, including frequent drug abuse or a considerable drug abuse in an individual case.

Publication Types